Filing Details

Accession Number:
0001209191-21-063053
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-11-05 11:15:57
Reporting Period:
2021-11-02
Accepted Time:
2021-11-05 11:15:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
19584 Chemed Corp CHE Services-Home Health Care Services (8082) 310791746
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1676780 Michael Nicholas Westfall 255 East Fifth Street
Suite 2600
Cincinnati OH 45202
Executive Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Capital Stock Disposition 2021-11-02 1,418 $490.15 6,060 No 4 S Direct
Capital Stock Disposition 2021-11-03 4,176 $485.24 1,884 No 4 S Direct
Capital Stock Acquisiton 2021-11-04 1,418 $231.91 3,302 No 4 M Direct
Capital Stock Acquisiton 2021-11-04 4,176 $231.91 7,478 No 4 M Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 M Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Capital Stock stock option(right to buy with tandem tax withholding) Disposition 2021-11-04 1,418 $231.91 1,418 $231.91
Capital Stock stock option(right to buy with tandem tax withholding) Disposition 2021-11-04 4,176 $231.91 4,176 $231.91
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
63,141 2022-11-03 No 4 M Direct
58,965 2022-11-03 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $490.00 to $490.26. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within ranges set forth in footnote (1) to this Form 4.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $485.00 to $485.75. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
  3. Vesting in three equal annual installments commencing 11/03/2018